Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Loyse

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|March 13, 2009
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar puncturesTihana Bicanic, Annemarie E Brouwer, Graeme Meintjes, et al.
The Lancet. Infectious Diseases|May 10, 2017
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysisRadha Rajasingham, Rachel M Smith, Benjamin J Park, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2014
Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitisJoseph N Jarvis, Tihana Bicanic, Angela Loyse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2011
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitisAngela Loyse, Douglas Wilson, Graeme Meintjes, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2011
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practiceAnn Sturdy, Anna Goodman, Ricardo J José, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2020
Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy StudiesElvis Temfack, Jean Joel Bigna Rim, Rene Spijker, et al.
The Lancet. Infectious Diseases|April 19, 2021
Cryptococcal meningoencephalitis: time for actionKatharine Elizabeth Stott, Angela Loyse, Joe N Jarvis, et al.
Medical Mycology|November 12, 2023
Genetic diversity and microevolution in clinical Cryptococcus isolates from CameroonPoppy Sephton-Clark, Elvis Temfack, Jennifer L Tenor, et al.
The Lancet. Global Health|November 4, 2024
Resolving the CD4-testing crisis to help end AIDS-related deathsOmar Syarif, Rita Oladele, Tinne Gils, et al.
The Journal of Clinical Investigation|April 19, 2014
Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosisWilber Sabiiti, Emma Robertson, Mathew A Beale, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|March 13, 2009
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar puncturesTihana Bicanic, Annemarie E Brouwer, Graeme Meintjes, et al.
The Lancet. Infectious Diseases|May 10, 2017
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysisRadha Rajasingham, Rachel M Smith, Benjamin J Park, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2014
Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitisJoseph N Jarvis, Tihana Bicanic, Angela Loyse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2011
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitisAngela Loyse, Douglas Wilson, Graeme Meintjes, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2011
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practiceAnn Sturdy, Anna Goodman, Ricardo J José, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2020
Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy StudiesElvis Temfack, Jean Joel Bigna Rim, Rene Spijker, et al.
The Lancet. Infectious Diseases|April 19, 2021
Cryptococcal meningoencephalitis: time for actionKatharine Elizabeth Stott, Angela Loyse, Joe N Jarvis, et al.
Medical Mycology|November 12, 2023
Genetic diversity and microevolution in clinical Cryptococcus isolates from CameroonPoppy Sephton-Clark, Elvis Temfack, Jennifer L Tenor, et al.
The Lancet. Global Health|November 4, 2024
Resolving the CD4-testing crisis to help end AIDS-related deathsOmar Syarif, Rita Oladele, Tinne Gils, et al.
The Journal of Clinical Investigation|April 19, 2014
Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosisWilber Sabiiti, Emma Robertson, Mathew A Beale, et al.
Pageof 6